CA2342027A1 - Proteines bag et molecules d'acide nucleique les codant - Google Patents

Proteines bag et molecules d'acide nucleique les codant Download PDF

Info

Publication number
CA2342027A1
CA2342027A1 CA002342027A CA2342027A CA2342027A1 CA 2342027 A1 CA2342027 A1 CA 2342027A1 CA 002342027 A CA002342027 A CA 002342027A CA 2342027 A CA2342027 A CA 2342027A CA 2342027 A1 CA2342027 A1 CA 2342027A1
Authority
CA
Canada
Prior art keywords
seq
pro
ser
glu
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342027A
Other languages
English (en)
Inventor
John C. Reed
Shinichi Takayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342027A1 publication Critical patent/CA2342027A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne une famille de protéines se rapportant aux BAG-1 provenant de l'homme (BAG-1L, BAG-1, BAG-2, BAG-3, BAG-4 et BAG-5), de l'invertébré C. elegans (BAG-1, BAG-2) et de la levure de fission S. pombe (BAG-1A, BAG-1B). L'invention concerne également les molécules d'acide nucléique les codant.
CA002342027A 1998-09-09 1999-09-09 Proteines bag et molecules d'acide nucleique les codant Abandoned CA2342027A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15048998A 1998-09-09 1998-09-09
US09/150,489 1998-09-09
PCT/US1999/021053 WO2000014106A1 (fr) 1998-09-09 1999-09-09 Proteines bag et molecules d'acide nucleique les codant

Publications (1)

Publication Number Publication Date
CA2342027A1 true CA2342027A1 (fr) 2000-03-16

Family

ID=22534770

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342027A Abandoned CA2342027A1 (fr) 1998-09-09 1999-09-09 Proteines bag et molecules d'acide nucleique les codant

Country Status (5)

Country Link
EP (1) EP1109824A4 (fr)
JP (1) JP2002524068A (fr)
AU (1) AU774355B2 (fr)
CA (1) CA2342027A1 (fr)
WO (1) WO2000014106A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004343A2 (fr) * 1999-07-09 2001-01-18 The Burnham Institute Procede permettant d'etablir un pronostic pour des patients atteints d'un cancer, par mesure des niveaux d'expression de la proteine bag
EP1323733A1 (fr) * 2001-12-28 2003-07-02 Arturo Leone Utilisation des séquences nucléotidique et protéique de BAG3 pour la recherche, le diagnostic et le traitement de maladies impliquant la mort cellulaire
US20030175958A1 (en) * 2002-03-15 2003-09-18 Reed John C. Methods for using bag expression as a cell differentiation agent and marker
WO2005054868A1 (fr) * 2003-12-05 2005-06-16 Multimmune Gmbh Compositions et procedes pour traiter et diagnostiquer des maladies neoplasiques et infectieuses
ITMI20130403A1 (it) 2013-03-18 2014-09-19 Biouniversa Srl Anticorpi anti-bag3 per uso terapeutico
KR102241558B1 (ko) * 2019-02-12 2021-04-20 주식회사 메드팩토 Bag2 폴리펩티드 또는 이의 단편에 특이적으로 결합하는 항체 또는 그의 항원 결합 단편
KR102172541B1 (ko) * 2019-02-12 2020-11-02 주식회사 메드팩토 Bag2 항체를 이용한 암 진단용 조성물 및 이를 이용한 방법
CN109913478A (zh) * 2019-04-09 2019-06-21 贵州大学 一种高粱E3泛素连接酶SbBAG4基因及其重组载体和表达方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539094A (en) * 1993-11-12 1996-07-23 La Jolla Cancer Research Foundation DNA encoding Bcl-2-associated proteins
US5652223A (en) * 1994-03-14 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA encoding CAI resistance proteins and uses thereof

Also Published As

Publication number Publication date
WO2000014106A9 (fr) 2000-06-22
AU774355B2 (en) 2004-06-24
EP1109824A1 (fr) 2001-06-27
WO2000014106A1 (fr) 2000-03-16
AU6038399A (en) 2000-03-27
JP2002524068A (ja) 2002-08-06
EP1109824A4 (fr) 2002-06-05

Similar Documents

Publication Publication Date Title
US7982023B2 (en) Bag proteins and nucleic acid molecules encoding them
CA2265912C (fr) Polypeptides de bad humaine codant des acides nucleiques et leurs procedes d'utilisation
AU2001263952B2 (en) Tumour suppressor and uses thereof
AU774355B2 (en) Novel bag proteins and nucleic acid molecules encoding them
US20020019000A1 (en) Polynucleotides coexpressed with matrix-remodeling genes
US6171857B1 (en) Leucine zipper protein, KARP-1 and methods of regulating DNA dependent protein kinase activity
WO2001026678A1 (fr) Segments courts de dap (protéine associée à l'apoptose) kinase
JP2004537295A (ja) 核酸結合タンパク質
CA2403750A1 (fr) Proteine 1 interagissant avec la survivine humaine (sip-1)
CA2525255A1 (fr) Proteines bzip minimalistes et utilisations de ces proteines
AU2002228077B2 (en) Histidine phosphatase interacting protein with 240KD
AU713686B2 (en) EB1 gene product binds to APC
US20040072163A1 (en) Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis
CA2340617A1 (fr) Genes associes a la maturation moleculaire de neurotransmetteurs
JP2005504509A (ja) 核酸関連タンパク質
US20040224392A1 (en) Novel human 26649, 3259, 57809, 57798, 33358, and 32529 molecules and uses therefor
JP2000083672A (ja) アポトーシス関連タンパク質
WO2001057185A2 (fr) Molecules de la famille des proteines de type card et leur utilisation
JP2005508600A (ja) 核酸関連タンパク質
WO2003066652A2 (fr) Proteine d'echafaudage cytoplasmique jlp et acides nucleiques codant celle-ci
AU2002228077A1 (en) Histidine phosphatase interacting protein with 240KD
KR20010086407A (ko) 칼륨 채널 상호작용물질 및 이의 용도
CA2385633A1 (fr) Paralogue de la proteine de liaison de calcium cytoplasmique induuite par un traumatisme cranien
CA2405985A1 (fr) Facteur de transcription d'homeoboite nk-2
AU2002252983A1 (en) Histidine phosphatase interacting protein of 120KD

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead